Press Room

CSF Europe 2024 - Compaction Simulation Forum

Start
Tuesday, June 04, 2024 - 16:49
End
Thursday, June 06, 2024 - 18:00
Location: Dublin, Ireland
CSF Conference João Henriques speaker | Hovione

CSF Workshop: Overcoming The Challenge of Poorly Soluble Drugs

This workshop delves into the complexities surrounding the formulation of poorly soluble drugs, a prevalent concern affecting a significant percentage of active pharmaceutical ingredients. Explore the scientific nuances of amorphous forms and their role in amorphous solid dispersions (ASDs), offering insights into enhanced solubility and dissolution. 

Our expert, João Henriques, Director, Oral Drug Product Development will lead the Workshop Session: Process Development and Scale-Up of Spray Drying

Join the session for an academic exploration where knowledge converges with scientific rigor, providing a thorough understanding of the formulation intricacies of poorly soluble drugs.
 
Key learnings:

  • Expand on your foundations and principles of spray drying for ASDs, from lab-scale development tools to the scale-up of processes and gain valuable insights on how ASDs improve the solubility and bioavailability of poorly soluble drugs.
  • Overcome solubility challenges with the best scale-up science, utilizing mechanistic and statistical modeling to delve into the impact of spray drying conditions and material attributes on downstream processing while leveraging our extensive expertise to ensure success from lab-scale to commercialization.

 

Do you want to know how Hovione can support your project? Schedule a meeting today.

schedule a meeting

 

 

 

 

Learn more about CSF Europe.

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025